Compass Consulting

What happens when a rare disease company in IND enabling phase needs a QA leader quickly? Our client, a biotechnology company specializing in rare diseases, urgently needed a Senior Director of Quality Assurance to lead their Quality Assurance department. The stakes were high, as the right leadership was essential to maintain product quality standards and regulatory compliance, directly impacting their market position and growth trajectory. Compass swiftly addressed our client's predicament by leveraging our deep talent pool and industry expertise. Our recruiter identified and presented a highly qualified candidate who perfectly aligned with the client's needs. This strategic placement solved multiple challenges: it filled a crucial leadership gap, brought in fresh perspectives to enhance our client's quality assurance protocols, and provided the confidence the client needed in their QA leadership. Plus, our efficient three-week placement process also allowed our client to maintain their operational momentum. With this key role filled by a top-tier professional, our client is now better positioned to ensure product excellence, maintain regulatory compliance, and drive their growth in the competitive biotech landscape. #PlacementSuccess #LifeSciencesStaffing #LifeSciencesRecruiting #Compass

Ready to accelerate your life sciences career? Browse our latest opportunities and join teams driving breakthrough discoveries: https://lnkd.in/gBhHXCx

We're searching for a Contract Manager II in South San Francisco to drive complex contract negotiations at a leading biotech company! ? Draft and negotiate highly complex contracts for Development Sciences ? Display high level of authority to make legal decisions ? Advise stakeholders on contractual terms and process efficiencies ? Serve as a resource, training other Contract Professionals $42-$82/hour for this onsite opportunity with a company making life-changing medicines! If you have 10+ years in contract management and thrive in fast-paced environments, this role is for you! ?? Apply now: https://lnkd.in/ei7HHsPx #BiotechJobs #ContractManager #Hiring #LifeSciences

At Compass, agility drives everything we do. We adapt to your timelines, budgets, and scope so that your projects stay on track with the right talent at the right time. Learn how we adapt to your needs: https://lnkd.in/etk3Ft4y

Former DeepMind scientist Simon Kohl recently raised $50M to launch Latent Labs, a startup aiming to revolutionize pharmaceutical research. By leveraging generative AI, they're making biology 'programmable' - potentially transforming how we discover and develop life-saving drugs. https://lnkd.in/eF25ZPN2

Every successful placement represents the start of a new journey. From interview preparation to thoughtful welcome cards, we're dedicated to creating exceptional experiences for life sciences professionals. Hear what our consultants say about working with Compass.

We’re searching for an Associate Director, Scientific Communications in San Rafael, CA to drive impactful medical and scientific storytelling in the biotech space. ?? Hybrid role – work flexibly while making a big impact! ? Lead strategic communications for groundbreaking therapies ? Collaborate with cross-functional teams to ensure scientific accuracy ? Shape key messaging for publications, presentations, and regulatory submissions If you have a passion for translating complex science into compelling narratives, this role is for you! ?? Apply now: https://lnkd.in/eC6AUYkw #BiotechJobs #ScientificCommunications #Hiring #MedicalAffairs #LifeSciences

?? Innovation is more than luck. It's about connecting the right experts with breakthrough opportunities. At Compass, we're proud to help shape the future of life sciences.

We're always thrilled to see companies focused on life-changing therapies for people with rare diseases. That's why we were so excited to see Astria Therapeutics, Inc.' news regarding the design of their ALPHA-ORBIT pivotal Phase 3 trial for navenibart for treating hereditary angioedema (HAE). For patients living with HAE, navenibart represents a potential breakthrough in treatment. This could mean giving patients the freedom to live their lives with fewer injections while still experiencing significant protection from painful and potentially life-threatening HAE attacks. Early trials showed an impressive 90-95% reduction in monthly attack rates We look forward to following the progress of the ALPHA-ORBIT trial. Read more here: https://lnkd.in/eYhS_mxM #BiotechInnovation #RareDisease #ClinicalTrials